期刊文献+

载脂蛋白E基因多态性与脑血管病的关系 被引量:3

The relationship between polymorphisms of apolipoprotein E gene and cerebrovascular disorder
下载PDF
导出
摘要 目的 探讨载脂蛋白 E ( APOE)基因多态性与脑血管病 ( CVD)的关系。方法 应用聚合酶链反应—限制性长度多态性技术 ( PCR-RFLP) ,检测 30例脑出血 ( CH)及 6 3例脑梗死 ( CI)患者的 APOE基因型 ,并与 6 6名同龄健康对照组比较。结果  CH组 APOE基因型ε4及ε4携带者的频率明显高于对照组 ( P<0 .0 5 ) ,ε3及ε3/3频率显著低于对照组 ( P<0 .0 1 ) ;CI组 APOE基因型 ε3/4明显高于对照组 ( P<0 .0 5 )。结论  APOE基因 ε3/4与 CI的发生相关 ,等位基因 ε4可能是 CVD的一种遗传易感因子 ,ε3/3可能与 CVD的保护有关。 Objective To study a relationship between the polymorphisms of apolipoprotein E(APOE) gene and Cerebrovascular disorder(CVD).Methods The polymerase chain reation(PCR)and restriction fragment length polymorphism(RFLP)technique were used to detect APOE genotype in 30 Cerebral hemorrhage(CH),63 Cerebral infarction(CI)patients and 66 age matched controls.Results The frequency of genotype ε4 and ε4 carrier in the CH group was significantly higher(P<0.05),whereas ε3 and ε3/3 was significantly lower(P<0.01),and ε3/4 in the CI group was significantly higher(P<0.05)when compared with controls,respectively. Conclusions APOE genotype ε3/4 might be responsible for the development of CI and allele ε4 seemed to be a genetic susceptible factor. On the contrast,ε3/3 might be related to the protection of CVD.
出处 《心脑血管病防治》 2001年第3期17-19,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
关键词 载脂蛋白E 基因多态性 脑血管病 Apolipoprotein E Polymorphism Cerebral hemorrhage Cerebral infarction
  • 相关文献

参考文献12

  • 1Siest G, Pillot T, Regis-bailly A, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine.Clin Chem, 1995, 41:1068~1086.
  • 2Kuusi T, Nieminen MS, Ehnholm C, et al. Apolipoprotein E polymorphism and coronary artery diseasa-increased prevalence of apolipoprotein E4 in angiograpically verified coronary patients. Arteriosclerosis. 1989, 9:237~241.
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33009
  • 4Richard P, Thomas G, Zulueta MP, et al. Common and rare genotypes of human aplipoprotein E deterimind by specific restriction profiles of polymeraes chain reaction-amphlified DNA. Clin Chem, 1994, 40:24~29.
  • 5Couderc R, Mahieux F, Bailleul S, et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke, 1993, 24:661~664.
  • 6Pedro-Botet J, Senti M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Stroke,1992, 23:1556~1562.
  • 7Basun H, Corder Eh, Guo Z, et al. Apolipoprotein E polymorphism and stroke in a population Sample aged 75 yeas or more. Stroke, 1996, 27:1310~1315.
  • 8Alberts M J, Graffagnino C, McClenny C, et al. Apo E genotype and survival from intracerebral haemorrhage. Lancet,1995, 346:575~579.
  • 9Nicoll JAR, Burnett C, Love S, et al. High frequency of apolipoprotein E ε2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol, 1996, 39:682~683.
  • 10Wilson PWF, Myers RH, Larson MG, et al. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. JAMA.1994, 272:1666~1671.

共引文献33008

同被引文献53

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部